The efforts of researchers dealing with stem cells in clinics around the world are still aiming
to ensure that only the desired, beneficial stem cells can be isolated from the patient's tissue (eg, adipose tissue or bone marrow) and transplanted. Luna Laboratory now has a patented, unique technology that allows a SAFE TRANSFER of the STEM CELLS selected from the bone marrow.
Safe therapy without complications - how is it possible?
• Developed by Luna Laboratory and administered during the therapy, the drug is
manufactured individually for a given patient, based on its own stem cells, which excludes the risk of transmission of diseases, the occurrence of a serological conflict or allergic reactions.
• Non-hematopoietic bone marrow cells of the patient are used, which do not show
immunogenicity, and therefore will not be rejected by the body as a transplant.
• Thanks to the unique cell selection technology developed by Luna Laboratory, the patient
is given only the most "beneficial", having the highest therapeutic potential of stem cells, while there are no self-reactive immune cells directed against their own tissues.
The therapy we propose not only inhibits the progression of the disease, but also causes
the resolution of many symptoms accompanying MS.
In all patients who have been subjected to individual cell therapy so far, a significant
improvement in their health condition was found, above all, improvement in mobility. It is so large that it allows patients to return to their former activities, work, and even to dance or sport.
Systematic check-ups of these patients, including the latest neurological tests carried out three years after the implementation of the therapy, showed strong repair processes: not only inhibition of the disease progression, but also the resolution of many symptoms accompanying MS. Depending on the individual case, there was a reduction or complete resolution of symptoms such as: visual impairment, balance disorders, limb paresis, spasticity, and sensory disturbances.
Neurological studies have shown that the EDSS index decreased. [EDSS scale, Expanded Disability Status Scale, is the basic tool for determining the degree of disability and progression of symptoms in people with multiple sclerosis.] Also, magnetic resonance imaging showed a reduction in pathological changes within the central nervous system.
„... we gave once drug containing stem cells via an intravenous infusion. We had a small
group of patients, because a group of four people is not a large group, but in all four people there was a very beneficial reaction of the body in the form of a reduction in EDSS, as well as, what is not without significance, there were no side effects, no complications in during and after the transfer of stem cells. These patients, in my opinion as a neurologist, recover. ”
prof. dr hab. n. med. Andrzej Klimek, neurologist
The strong repair processes caused by the therapy are explained by the effect of stem
cells, which in this way perform their natural function in the body.
Therapy does not entail any additional risk of developing complications, conditions and
conditions that accompany or develop as a result of MS.
The autologous stem cell transfer used by us, in which the donor and recipient are the
same person, is the safest type of transplant - it does not result in the immunological reaction of tissue incompatibility and rejection of the transfer. It does not carry the risk of transmitting infectious diseases. There is also no risk of serological conflict or allergic reaction, because these cells are the cells of the patient and are not rejected by his organism. These cells immediately incorporate all of their therapeutic mechanisms, which translates directly into their high effectiveness in the treatment of MS. None of our patients also had complications during the transfer of stem cells.
LIMITATION OR TOTAL DISCONTINUATION PHARMACOLOGICAL TREATMENT
During observation of patients treated with autologous transfer of stem cells, none of the
participants of the therapy took other medications recommended for the treatment of causative multiple sclerosis. The only form of additional treatment used by our patients was diet supplementation with vitamin preparations.
LIFE WITHOUT PAIN
Relief of painful muscle stiffness, headaches or chronic pain associated with MS is, apart
from the general improvement in mobility, the most frequently felt and appreciated by patients effects of stem cell therapy. Cell therapy does not only endure chronic pain, which suffers from MS patients, but also
relieves the patient from painful procedures (everyday injections, painful medical diagnosis).
After one-time administration of stem cells, the patient remains only under the supervisionof a neurologist's physician aimed at long-term evaluation of the effects of therapy.